Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination

Por Datta, Jashodeep, Xu, Shuwen, Terhune, Julia H, Rosemblit, Cinthia, Berk, Erik, Fitzpatrick, Elizabeth, Czerniecki, Brian J
Publicado no J Immunother Cancer (2014)

Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy

Por Datta, Jashodeep, Terhune, Julia H., Lowenfeld, Lea, Cintolo, Jessica A., Xu, Shuwen, Roses, Robert E., Czerniecki, Brian J.
Publicado no Yale J Biol Med (2014)